Long-term follow-up of lymphocyte subpopulations and intracellular cytokines in patients with ANCA-associated vasculitis treated with rituximab

被引：0
|
作者：
Hruskova, Zdenka [1 ,2 ]
Mareckova, Helena [2 ,3 ]
Jancova, Eva [1 ,2 ]
Rysava, Romana [1 ,2 ]
Tesar, Vladimir [1 ,2 ]
机构：
[1] Charles Univ Prague, Dept Nephrol, Gen Teaching Hosp, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Charles Univ Prague, Inst Microbiol & Immunol, Gen Teaching Hosp, Prague, Czech Republic
来源：
APMIS | 2009年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [31] Lymphocyte counts in patients with ANCA-associated vasculitis
    Andreas Holbro
    Philipp Schuetz
    Christoph Berger
    Christoph Hess
    Thomas Daikeler
    Rheumatology International, 2009, 29 : 807 - 810
  • [32] Lymphocyte counts in patients with ANCA-associated vasculitis
    Holbro, Andreas
    Schuetz, Philipp
    Berger, Christoph
    Hess, Christoph
    Daikeler, Thomas
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (07) : 807 - 810
  • [33] LONG-TERM FOLLOW UP OF A GLUCOCORTICOID-MINIMIZING REGIMEN FOR REMISSION-INDUCTION IN ANCA-ASSOCIATED VASCULITIS
    Mcadoo, Stephen
    Pepper, Ruth
    Hamour, Sally
    Burns, Aine
    Little, Mark
    Cairns, Thomas
    Salama, Alan
    Pusey, Charles
    RHEUMATOLOGY, 2019, 58
  • [34] Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis
    Sanchez alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Faurschou, Mikkel
    Flossmann, Oliver
    Hauser, Thomas
    Hruskova, Zdenka
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    akesson, Anna
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (07) : 1655 - 1665
  • [35] Risk of malignancy with long-term immunosuppression in ANCA-associated vasculitis
    Rahmattulla, C.
    Goceroglu, A.
    Reinders, M. E. J.
    Hagen, E. C.
    Bruijn, J. A.
    Bajema, I. M.
    PRESSE MEDICALE, 2013, 42 (04): : 767 - 767
  • [36] LONG-TERM MORTALITY AND COMPLICATIONS IN YOUNG AND ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Berti, A.
    Felicetti, M.
    Padoan, R.
    Brunori, G.
    Schiavon, F.
    Paolazzi, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 604 - 604
  • [37] Infections in ANCA-associated vasculitis and lupus nephritis treated with rituximab
    Temiz, Sultan Gozde
    Barutcu Atas, Dilek
    Alibaz Oner, Fatma
    Velioglu, Arzu
    Hakki Arikan, Izzet
    Tuglular, Zubeyde Serhan
    Direskeneli, Rafi Haner
    Asicioglu, Ebru
    MARMARA MEDICAL JOURNAL, 2024, 37 (03): : 268 - 273
  • [38] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Nadezhda Wall
    Lorraine Harper
    Nature Reviews Nephrology, 2012, 8 : 523 - 532
  • [39] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Wall, Nadezhda
    Harper, Lorraine
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (09) : 523 - 532
  • [40] ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
    van Dam, Laura
    Dirikgil, Ebru
    Bredewold, Edwin
    Ray, Argho
    Rabelink, Ton
    van Kooten, Cees
    Teng, Onno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345